{"result": {"id": "8a769b40-df58-490c-a9ce-5c4fc6c68b92", "choices": [{"finish_reason": "stop", "index": 0, "logprobs": null, "message": {"content": "(\"entity\"<|>RENAL DENERVATION<|>ORGANIZATION<|>A device-based treatment for resistant hypertension\")  \n##\n(\"entity\"<|>SPIRONOLACTONE<|>ORGANIZATION<|>An aldosterone receptor antagonist used for hypertension\")  \n##\n(\"entity\"<|>EPLERENONE<|>ORGANIZATION<|>An aldosterone receptor antagonist used for hypertension\")  \n##\n(\"entity\"<|>FUROSEMIDE<|>ORGANIZATION<|>A loop diuretic used in advanced chronic kidney disease\")  \n##\n(\"entity\"<|>SLEEP APNEA SYNDROME<|>ORGANIZATION<|>A condition associated with resistant hypertension\")  \n##\n(\"entity\"<|>SECONDARY HYPERTENSION<|>ORGANIZATION<|>Hypertension caused by underlying conditions\")  \n##\n(\"entity\"<|>RENAL PARENCHYMAL HYPERTENSION<|>ORGANIZATION<|>Hypertension caused by kidney disease\")  \n##\n(\"relationship\"<|>SPIRONOLACTONE<|>EPLERENONE<|>Both are aldosterone receptor antagonists used for hypertension<|>8)  \n##\n(\"relationship\"<|>FUROSEMIDE<|>CKD<|>Furosemide is used in advanced chronic kidney disease patients<|>7)  \n##\n(\"relationship\"<|>SLEEP APNEA SYNDROME<|>CPAP<|>CPAP is used to treat sleep apnea syndrome<|>9)  \n##\n(\"relationship\"<|>SECONDARY HYPERTENSION<|>RENAL PARENCHYMAL HYPERTENSION<|>Renal parenchymal hypertension is a type of secondary hypertension<|>8)  \n##\n(\"relationship\"<|>RENAL DENERVATION<|>SECONDARY HYPERTENSION<|>Renal denervation may be used for certain cases of secondary hypertension<|>6)  \n<|COMPLETE|>", "refusal": null, "role": "assistant", "annotations": null, "audio": null, "function_call": null, "tool_calls": null}}], "created": 1751558777, "model": "deepseek-chat", "object": "chat.completion", "service_tier": null, "system_fingerprint": "fp_8802369eaa_prod0623_fp8_kvcache", "usage": {"completion_tokens": 441, "prompt_tokens": 2867, "total_tokens": 3308, "completion_tokens_details": null, "prompt_tokens_details": {"audio_tokens": null, "cached_tokens": 2816}, "prompt_cache_hit_tokens": 2816, "prompt_cache_miss_tokens": 51}}, "input": {"messages": [{"content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: �运 动 ,减重 ,避免熬夜和改善睡眠质量等 ;\n　　　(6) 评 估 和 调 整 降 压 方 案 , 常 用 药 物 包 括 长 效 CCB、ACEI、ARB、ARNI、噻嗪类利尿剂 , 对于 CKD 分期 4期以上患者 ,可使用袢利尿剂如呋塞米 ;\n　　　(7)如血压仍未控制 ,可考虑加用第 4种降压药 , 首选醛固酮受体拮抗剂 ,如螺内酯、依普利酮 ,其他药 物如 β受体阻滞剂、α受体阻滞剂、复方保钾利尿剂及 新型降压药(内皮素双受体拮抗剂等) ; 同时也需积极 寻找其他导致血压升高的继发性因素 ;\n　　　(8)对于特殊人群 ,如难治性高血压合并睡眠呼吸  暂停综合征 ,可通过使用持续气道正压通气(continu- ouspositiveairwaypressure,CPAP)改善血压控制 ;\n　　　(9)评估是否存在睡眠障碍以及精神压力过大等 情况 ,推荐至相应专科进行诊治 ;\n　　　(10)部分难治性高血压患者经高血压专科医生等 综合评估后 ,可考虑尝试 RDN等器械治疗 ,具体见本 指南高血压的器械治疗部分。\n\n10  继发性高血压\n　　　继发性高血压在高血压患者中约占 10% ,但不少  来自特定人群的研究结果显示其占比可能更高 。继发  性高血压是其他疾病或病理生理状态导致的高血压 ,  涉及肾及肾血管、内分泌、睡眠呼吸、自身免疫、神经、 血液等多个系统的多种疾病以及药物、机械血流障碍、 单基因突变等病理生理状态 。继发性高血压除高血压  造成的心血管危害以外 , 与之伴随的低血钾、RAS激  活、高醛固酮、高皮质醇、高儿茶酚胺、低氧血症等还可  导致独立于高血压之外的心血管损害。\n　10.1   肾实质性高血压  肾实质性高血压是目前继发 性高血压最常见的原因之一 。 肾实质疾病按照主要累 及部位可以分为肾小球疾病 , 肾小管-间质疾病或者肾 小血管疾病 ;按照病因可以分为原发性 ,继发性 , 以及 先天性/遗传性肾实质疾病 。任何类型的肾实质病变 均可能影响肾脏对血压的调控 ,导致高血压的发生及 持续 。其发生机制目前认为是肾脏水钠排泄受损导致 的水钠潴留 ,交感神经系统兴奋性增高 ,RAS过度活 化 , 以及血管僵硬度增加等多种因素相互促进、综合作 用的结果。\n　　　肾实质性高血压患者临床表现多样 ,多有尿检异 常 ,包括不同程度的�\n######################\nOutput:", "role": "user"}, {"role": "assistant", "content": "(\"entity\"<|>CCB<|>ORGANIZATION<|>Long-acting calcium channel blockers used in hypertension treatment\")  \n##\n(\"entity\"<|>ACEI<|>ORGANIZATION<|>Angiotensin-converting enzyme inhibitors used in hypertension treatment\")  \n##\n(\"entity\"<|>ARB<|>ORGANIZATION<|>Angiotensin receptor blockers used in hypertension treatment\")  \n##\n(\"entity\"<|>ARNI<|>ORGANIZATION<|>Angiotensin receptor-neprilysin inhibitors used in hypertension treatment\")  \n##\n(\"entity\"<|>CKD<|>ORGANIZATION<|>Chronic kidney disease, a condition affecting kidney function\")  \n##\n(\"entity\"<|>CPAP<|>ORGANIZATION<|>Continuous positive airway pressure, a treatment for sleep apnea\")  \n##\n(\"entity\"<|>RDN<|>ORGANIZATION<|>Renal denervation, a device-based treatment for hypertension\")  \n##\n(\"entity\"<|>RAS<|>ORGANIZATION<|>Renin-angiotensin system, involved in blood pressure regulation\")  \n##\n(\"relationship\"<|>CCB<|>ACEI<|>Both are classes of drugs used in hypertension treatment<|>5)  \n##\n(\"relationship\"<|>ARB<|>ACEI<|>Both are classes of drugs targeting the renin-angiotensin system<|>6)  \n##\n(\"relationship\"<|>ARNI<|>ARB<|>ARNI includes ARB components in its mechanism<|>7)  \n##\n(\"relationship\"<|>CKD<|>RAS<|>Chronic kidney disease often involves dysregulation of the renin-angiotensin system<|>6)  \n##\n(\"relationship\"<|>CPAP<|>RDN<|>Both are treatments for conditions related to hypertension (sleep apnea and resistant hypertension)<|>4)  \n<|COMPLETE|>"}, {"content": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "role": "user"}], "parameters": {"model": "deepseek-chat", "frequency_penalty": 0.0, "max_tokens": 4000, "n": 1, "presence_penalty": 0.0, "temperature": 0.0, "top_p": 1.0}}, "key": "chat_extract-continuation-0_41c6c7809eb829b7d5776f147cb2e52c7f49f95989df397540d54aac7d10c58c_v2"}